Table of Contents

company-logo

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

AnaptysBio Dividend Announcement

• AnaptysBio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on AnaptysBio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

AnaptysBio Dividend History

AnaptysBio Dividend Yield

AnaptysBio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing AnaptysBio stock? Use our calculator to estimate your expected dividend yield:

AnaptysBio Financial Ratios

P/E ratio-4.20
PEG ratio0.03
P/B ratio8.25
ROE-287.94%
Payout ratio0.00%
Current ratio10.23
Quick ratio10.23
Cash Ratio4.37

AnaptysBio Dividend FAQ

Does AnaptysBio stock pay dividends?
AnaptysBio does not currently pay dividends to its shareholders.
Has AnaptysBio ever paid a dividend?
No, AnaptysBio has no a history of paying dividends to its shareholders. AnaptysBio is not known for its dividend payments.
Why doesn't AnaptysBio pay dividends?
There are several potential reasons why AnaptysBio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will AnaptysBio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While AnaptysBio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is AnaptysBio a dividend aristocrat?
AnaptysBio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AnaptysBio a dividend king?
AnaptysBio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AnaptysBio a dividend stock?
No, AnaptysBio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy AnaptysBio stocks?
To buy AnaptysBio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy AnaptysBio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.